Join the Prostate Cancer group to help and get support from people like you.
Prostate Cancer News
Related terms: Cancer, Prostate, Carcinoma of Prostate
Acute Cystitis Tied to Higher Risk for Urogenital Cancers
FRIDAY, Sept. 26, 2025 – Acute cystitis may signal the presence of urogenital cancers in middle-aged adults, according to a study published online Sept. 16 in BMJ Public Health. Filip Jansåker, M...
Wrist Cooling May Help Manage Vasomotor Symptoms
WEDNESDAY, Sept. 24, 2025 – Targeted wrist cooling may offer a safe approach for managing vasomotor symptoms, according to a study published online Sept. 20 in Endocrinology and Diabetes. Nazlı U...
Foresee Pharmaceuticals Announces FDA Approval of Camcevi ETM for the Treatment of Advanced Prostate Cancer
Taipei, Taiwan, August 28th, 2025 – Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Cam...
Biparametric MRI Noninferior for Diagnosing Prostate Cancer
FRIDAY, Sept. 12, 2025 – Biparametric magnetic resonance imaging (MRI), which omits the gadolinium contrast sequence used in multiparametric MRI, is noninferior for diagnosing prostate cancer,...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 – A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of eBioMedicine. Menglang Yuan,...
Advanced Prostate Cancer Cases Rising as Fewer Men Are Screened, New Report Says
THURSDAY, Sept. 4, 2025 — Prostate cancer rates are climbing in the U.S. with more men being diagnosed at later stages when the disease is harder to treat, researchers report. The analysis — pub...
Prostate Cancer Incidence Trends Increasing
WEDNESDAY, Sept. 3, 2025 – Prostate cancer incidence is increasing, according to a report published online Sept. 2 in CA: A Cancer Journal for Clinicians. Tyler B. Kratzer, M.P.H., from the American...
Most Don't Know Prostate Cancer Can Be a Silent Killer, Poll Finds
TUESDAY, Sept. 2, 2025 — Too often, American men and their loved ones mistakenly believe that prostate cancers must always present with symptoms, a new poll shows. Of the people polled, 4 out of 5 p...
Many Cancer Patients Say Doctors Aren't Honoring Their Treatment Desires
TUESDAY, Aug. 26, 2025 — Frequently, patients with advanced cancer simply want to be made as comfortable as possible as they wind down their final days. Doctors aren’t listening to their desires, a ne...
About One in Six Men With Grade Group 1 Prostate Cancer Has Intermediate-, High-Risk Disease
WEDNESDAY, Aug. 6, 2025 – A proportion of men with grade group 1 (GG1) prostate cancer have a higher-risk disease than suggested by biopsy, according to a study published online July 31 in JAMA...
Are Some 'Low-Grade' Prostate Cancers More Deadly Than Thought?
FRIDAY, August 1, 2025 — Men diagnosed with what are known as Grade Group one (GG1) prostate tumors are often told they don’t require treatment, only “watchful waiting,” because GG1 cancers are at low...
Racial Differences Seen in Prostate Cancer Care Quality
WEDNESDAY, July 30, 2025 – Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared with White men, according to a research letter...
Risk for Death From Prostate Cancer Low With Guideline Care for Nonmetastatic Disease
MONDAY, July 14, 2025 – Men with nonmetastatic prostate cancer receiving guideline-concordant care have a much higher risk for death from causes other than prostate cancer, according to a study...
ESPN's Jay Harris Diagnosed With Prostate Cancer
FRIDAY, June 6, 2025 — Longtime ESPN “SportsCenter” anchor Jay Harris has been diagnosed with prostate cancer and is scheduled to have surgery on June 10. Harris, 60, wrote about his experience in an ...
U.S. FDA Approves Third Indication of Nubeqa (darolutamide) for Patients with Advanced Prostate cancer
Berlin, June 3, 2025 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved its oral androgen receptor inhibitor (ARi) Nubeqa (darolutamide) in combination with a...
Further information
Related condition support groups
Related drug support groups
Lupron, Lupron Depot, estradiol, Premarin, Estrace, Xtandi, docetaxel, Zytiga